StonvexLoading…
StonvexCore line items from CRIS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.53M | $0.00 | $9.44M | $8.30M | $5.13M |
Operating Income | Not available | $-11.52M | $-5.71M | $-25.33M | $-18.41M |
Net Income | Not available | $-24.20M | $-7.58M | $-26.94M | $-8.59M |
EPS (Diluted) | $-0.42 | $-1.25 | $-0.58 | $-2.19 | $-1.82 |
Total Assets | Not available | $29.69M | $19.97M | $27.64M | $29.23M |
Total Liabilities | Not available | $16.98M | $14.50M | $42.33M | $43.22M |
Cash & Equivalents | Not available | $15.00M | $5.06M | $9.05M | $10.14M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 39.98M | 12.93M | 12.73M | 10.71M |